Eliem Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Eliem Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2024.
Eliem Therapeutics, Inc. Assets for the quarter ending June 30, 2024 was $226M, a 94.4% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$226M	+$110M	+94.4%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$109M	-$12.8M	-10.4%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$110M	-$24.5M	-18.2%	Dec 31, 2023	10-Q	2024-08-14
Q3 2023	$113M	-$28.1M	-20%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$116M	-$33.8M	-22.5%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$122M	-$40.3M	-24.8%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$135M	-$38.2M	-22.1%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$141M	-$41.4M	-22.7%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$150M	+$42.5M	+39.5%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$162M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$173M	+$149M	+603%	Dec 31, 2021	10-K	2023-03-06
Q3 2021	$182M			Sep 30, 2021	10-Q	2021-11-08
Q2 2021	$108M			Jun 30, 2021	10-Q	2021-09-13
Q4 2020	$24.6M			Dec 31, 2020	10-K	2022-03-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.